
Metagenomics (also referred to as community and environmental genomics), is the genomic study of microorganisms where the DNA of the microorganism is extracted directly and cloned from an assembly of the microorganism.Factors such as the development of inexpensive next generation sequencing (NGS) technologies, high throughput screening (HTS) methods, use of advanced bioinformatics tools such as genome assemblers & gene predictors, and recovery of many novel drugs, antibiotics, & enzymes or isoenzymes drive the market growth. However, limited accessibility of enzyme activity assay and the narrow choice of host in transformation acts as a constraint in the growth of the metagenomics market. In addition, R&D to identify new enzymes and antibiotics, and improved bioinformatics offer attractive opportunities for the key market players.